Preclinical Testing Services

Creative Biolabs provides a high-end suite of services designed to move biological candidates from the bench toward the next stage of development. We offer a full range of services including molecular characterization, efficacy modeling in advanced 3D systems, and safety profiling through high-throughput platforms. Through professional collaboration, investigators leverage specialized biological proficiency and comprehensive data architectures to facilitate internal decision-making, thereby optimizing the developmental trajectory for novel antibody and protein therapeutics. Our commitment resides in synthesizing the rigorous empirical evidence requisite for the robust validation of research objectives.

Introduction What We Can Offer How We Can Help Publication Why Choose Us Customer Reviews FAQs Related Services Contact Us

Foundational Principles of Modern Preclinical Research Strategies

Preclinical development of biologics. (Creative Biolabs AI)

Preclinical testing serves as the vital foundation for biological safety and efficacy assessment. Nonclinical evaluation is essential to define pharmacological and toxicological effects accurately. Current scientific literature emphasizes that the industry has shifted focus toward human-relevant models like Organ-on-a-Chip to improve translational success. Integrating advanced 3D biology with traditional toxicology is now the modern industry standard. This approach effectively reduces research attrition while ensuring rigorous biological safety across diverse development programs.

Request a Consultation →

What We Can Offer

One-Stop Custom Fermentation

We provide seamless transition services from laboratory-scale experiments to large-scale pilot production, ensuring a steady supply of high-quality biological materials for your preclinical research requirements.

Strain Stability & Optimization

Our experts provide rigorous quality assurance for strain origin while applying advanced codon optimization techniques to significantly facilitate robust expression levels in your selected microorganisms.

Efficient Upstream & Downstream Processing

We utilize advanced process development strategies to ensure the delivery of high-purity bioproducts with minimal endotoxin levels, specifically optimized for sensitive biological safety studies.

Advanced Quality Systems

We implement Quality-by-Design principles and sophisticated process analytical techniques to monitor and ensure the long-term stability and consistency of your compound across various batches.

How Creative Biolabs' service Can Assist Your Projects

Structure and Biochemical Characterization

We provide in-depth analysis of molecular weight, primary sequences, and higher-order structures to ensure the structural integrity and consistency of your biological research candidates.

Learn More →

Preclinical Testing-Bioassays & Immunoassays

Our experts conduct specialized assays tailored for monoclonal antibodies, conjugates, and recombinant proteins, focusing on high-resolution purity assessments and stability profiling across diverse conditions.

Learn More →

Efficacy Models

We utilize validated disease models, including sophisticated cell-based and tissue-based systems, to provide robust biological evidence of therapeutic potential and target engagement for your molecules.

Learn More →

Antibody & Protein Pharmacology Services

Our team delivers detailed pharmacokinetic profiling and target engagement assays to evaluate how your drug candidate interacts with biological systems and its metabolic fate.

Learn More →

Antibody and Protein Toxicology Services

We provide high-quality toxicology assessments, including comprehensive immunogenicity testing and cytokine monitoring, to identify potential biological safety risks early in the discovery phase.

Learn More →

Publication

This publication is a review of immune functional assays (IFAs) and their use in precision medicine. The paper highlights that an unbalanced immune response is involved in many diseases, and assessing a patient's immune profile is a challenge due to inter-individual variability. IFAs, which are assays that record a response to a given stimulation, are presented as a potential solution to this challenge.

The review discusses the use of IFA in various fields, including:

Diagnosing and managing infections

The publication uses tuberculosis as an example, detailing the progression from the classical tuberculin skin test (TST) to more modern interferon-gamma release assays (IGRAs).

Immune monitoring

The article explains how IFAs are used in diagnosing primary immune deficiencies (PIDs), managing allergies, and monitoring patients after solid organ or hematopoietic stem cell transplantation.

Sepsis

The review emphasizes the potential for IFAs to provide a comprehensive insight into immune functionality at the bedside, which is crucial for managing the dynamic and complex immune responses in sepsis.

The authors conclude that the design of new tools that provide a comprehensive and timely insight into immune functionality represents a significant step toward patient immunoprofiling.

Fig.1 Evaluation of immune function using interferon-gamma-based in vitro assays. (OA Literature)Fig.1 In vitro assays utilizing interferon-gamma. 1

Highlights

Scientific Excellence

Our team combines traditional biological expertise with modern discovery paradigms to provide a strategic narrative for your research portfolio, ensuring every dataset supports your project goals.

Human-Centric Focus

We prioritize microphysiological systems and humanized immune models to bypass the limitations of traditional testing, offering more accurate predictions of human biological responses during early discovery.

Service Features

Research Precision

Our scientists maintain a high success rate in supporting research filings through rigorous workflows, ensuring that every study meets the highest quality standards for reproducibility.

Innovative Analytics

We integrate Digital Pathology and advanced imaging technologies to allow for faster, deeper insights than standard providers, providing clear visual evidence to support your research findings.

Get a Quote - Partner with our elite team of scientists to transform your research concepts into validated milestones.

Customer Reviews

FAQs

How does Creative Biolabs handle the transition between different material grades?

We maintain high standards for research materials to ensure that early-stage data remains comparable to later results, effectively minimizing the risk of performance gaps during critical scale-up phases.

What is the benefit of your Digital Pathology service?

Our high-quality digital workflow facilitates remote, real-time peer review by top international specialists, which significantly reduces overall reporting timelines while increasing the clarity and depth of data analysis.

Related Services

One Stop Solutions for In Vitro ADME

We provide specialized in vitro ADME solutions designed for oncology, characterizing drug absorption, distribution, metabolism, and excretion. These assays optimize therapeutic strategies and predict interactions to enhance immunotherapy efficacy.

Learn More →

Our CDMO Service

We offer end-to-end development services for cancer immunotherapies, spanning target identification to preclinical validation. Our platform supports various modalities, including checkpoint inhibitors and cell therapies, ensuring robust biological characterization.

Learn More →

How to Contact Us

Ready to take the next step in your drug development journey? Our multidisciplinary team of scientists and research consultants is standing by to discuss your project specifics and design a custom testing strategy that aligns with your discovery milestones. By leveraging our advanced biological platforms and data-driven insights, you can mitigate early research risks and optimize the path for your biological candidates.

Contact Our Team for more information and to discuss your project.

Reference

  1. Albert-Vega, Chloé et al. "Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine." Frontiers in immunology vol. 9 2367. 16 Oct. 2018. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2018.02367
Loading case studies...
Online Inquiry